Vistin Pharma ASA: Mandatory notification of trade

Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure ASA is closely associated with board member Øystein Stray Spetalen.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment

• 20240926_Notification of trade_Saga i Vistin

You May Also Be Interested In

• Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
• MEXC's July Highlights: Stock Futures Volume Up 111%, Tokenized Equities Take 62% of TradFi Spot
• Global-e Achieves Significant GMV, Revenue and Profit Expansion in the Second Quarter of 2026, Raises Outlook for the Year